•
Jun 30, 2021

Stoke Therapeutics Q2 2021 Earnings Report

EPS
-$0.6
Previous year: -$0.39
+53.8%
Cash and Equivalents
$169M
Free Cash Flow
-$16.4M
Total Assets
$264M

Stoke Therapeutics

Stoke Therapeutics